Table 9.
Complication | OR (95 % CI) | P |
---|---|---|
Breast Complication | ||
Total Flap Loss | 11.21 (0.58–2143.39) | 0.12 |
Partial Flap Loss | 0.87 (0.20– 3.34) | 0.84 |
Free-Flap Necrosis | 0.82 (0.05 – 7.79) | 0.87 |
Fat Necrosis | 0.77 (0.43 – 1.35) | 0.36 |
Mastectomy Skin-Flap Necrosis | 2.87 (1.65 – 5.06) | < 0.01* |
Hematoma | 0.74 (0.31 – 1.67) | 0.48 |
Seroma | 0.98 (0.27– 3.26) | 0.98 |
Major Infection | 1.38 (0.31 – 6.61) | 0.67 |
Minor Infection (Cellulitis) | 1.19 (0.35 – 3.83) | 0.77 |
Delayed Wound Healing | 1.00 (0.23 – 3.87) | 0.99 |
Donor-Site Complication | ||
Delayed Wound Healing | 1.41 (0.55 – 3.61) | 0.47 |
Wound Dehiscence | 5.53 (1.33 – 32.28) | 0.02* |
Infection | 1.40 (0.36 – 5.06) | 0.61 |
Seroma | 1.22 (0.25 – 5.94) | 0.80 |
Abdominal Hernia or Bulge | 1.01 (0.41 – 2.36) | 0.99 |
OR, odds ratio; CI, confidence interval
Statistically significant (p < 0.05).
Each model included the following covariates: age at surgery, timing of reconstruction (immediate v. delayed), flap type (msTRAM v. perforator), laterality (unilateral v. bilateral), neoadjuvant chemotherapy, history of smoking, Charlson comorbidity index, and history of pre-operative radiation.